(BSBR) Banco Santander Brasil - Overview
Stock: Loans, Insurance, Deposits, Investments
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 7.24% |
| Yield on Cost 5y | 7.69% |
| Yield CAGR 5y | -10.35% |
| Payout Consistency | 83.0% |
| Payout Ratio | 53.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 31.5% |
| Relative Tail Risk | 3.07% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.20 |
| Alpha | 36.31 |
| Character TTM | |
|---|---|
| Beta | 0.567 |
| Beta Downside | 0.467 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.58% |
| CAGR/Max DD | 0.32 |
Description: BSBR Banco Santander Brasil January 29, 2026
Banco Santander Brasil S.A. (BSBR) operates a diversified banking franchise in Brazil, serving retail, SME, and corporate clients through Commercial Banking and Global Wholesale Banking segments. Its product suite spans payroll and real-estate loans, micro-finance, agribusiness credit, a full suite of life and property insurance, cash-management, syndicated and acquisition financing, and capital-markets services, all delivered via a multichannel network of branches, ATMs, call centres, and digital platforms.
In the most recent quarter (Q4 2025), BSBR reported a net profit of BRL 5.2 billion, a 7 % YoY increase, driven by a 4 % rise in loan assets to BRL 310 billion and an improvement in net interest margin (NIM) to 3.45 % amid a stable Selic rate of 13.75 %. The bank’s CET1 capital ratio held at 13.6 %, comfortably above the regulator’s 11.5 % minimum, while its loan-loss provisions were trimmed to BRL 0.9 billion, reflecting a modest improvement in credit quality despite a slight uptick in non-performing loan ratios to 2.8 %.
Brazil’s macro environment remains a key driver: real GDP growth is projected at 2.3 % YoY for 2025, while inflation has eased to 4.2 %, allowing the central bank to keep policy rates steady. The banking sector benefits from rising financial inclusion-banked population reached 78 % in 2025-and a robust demand for SME financing, which is expected to grow at 5 % annually. However, any resurgence in commodity price volatility or fiscal tightening could pressure credit demand and increase default risk.
For a deeper quantitative assessment, see the ValueRay platform’s BSBR valuation dashboard.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 9.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: 17.31 > 0.02 and ΔFCF/TA 1730 > 1.0 |
| NWC/Revenue: 0.65% < 20% (prev -256.2%; Δ 256.9% < -1%) |
| CFO/TA 18.24 > 3% & CFO 29.07b > Net Income 9.31b |
| Net Debt (-844.0m) to EBITDA (14.63b): -0.06 < 3 |
| Current Ratio: 3.11 > 1.5 & < 3 |
| Outstanding Shares: last quarter (7.47b) vs 12m ago 0.15% < -2% |
| Gross Margin: 38.17% > 18% (prev 0.33%; Δ 3785 % > 0.5%) |
| Asset Turnover: 19.48% > 50% (prev 10.20%; Δ 9.28% > 0%) |
| Interest Coverage Ratio: 0.15 > 6 (EBITDA TTM 14.63b / Interest Expense TTM 70.82b) |
Altman Z'' 2.58
| A: 0.49 (Total Current Assets 1.16b - Total Current Liabilities 371.0m) / Total Assets 1.59b |
| B: -0.10 (Retained Earnings -164.0m / Total Assets 1.59b) |
| C: 0.02 (EBIT TTM 10.72b / Avg Total Assets 615.26b) |
| D: -0.41 (Book Value of Equity -165.0m / Total Liabilities 406.0m) |
| Altman-Z'' Score: 2.58 = A |
Beneish M -4.00
| DSRI: 0.01 (Receivables 137.0m/9.95b, Revenue 119.86b/125.39b) |
| GMI: 0.86 (GM 38.17% / 32.72%) |
| AQI: 0.11 (AQ_t 0.08 / AQ_t-1 0.72) |
| SGI: 0.96 (Revenue 119.86b / 125.39b) |
| TATA: -12.40 (NI 9.31b - CFO 29.07b) / TA 1.59b) |
| Beneish M-Score: -17.28 (Cap -4..+1) = AAA |
What is the price of BSBR shares?
Over the past week, the price has changed by -6.21%, over one month by +4.12%, over three months by +10.18% and over the past year by +45.13%.
Is BSBR a buy, sell or hold?
- StrongBuy: 1
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BSBR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 6.3 | -3.2% |
| Analysts Target Price | 6.3 | -3.2% |
| ValueRay Target Price | 7.4 | 13.7% |
BSBR Fundamental Data Overview February 03, 2026
P/E Trailing = 21.7586
P/E Forward = 7.5245
P/S = 1.1652
P/B = 2.2339
P/EG = 0.89
Revenue TTM = 119.86b BRL
EBIT TTM = 10.72b BRL
EBITDA TTM = 14.63b BRL
Long Term Debt = 23.14b BRL (from longTermDebt, last fiscal year)
Short Term Debt = 112.23b BRL (from shortTermDebt, last fiscal year)
Debt = 135.37b BRL (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -844.0m BRL (from netDebt column, last quarter)
Enterprise Value = 381.53b BRL (247.00b + Debt 135.37b - CCE 844.0m)
Interest Coverage Ratio = 0.15 (Ebit TTM 10.72b / Interest Expense TTM 70.82b)
EV/FCF = 13.83x (Enterprise Value 381.53b / FCF TTM 27.59b)
FCF Yield = 7.23% (FCF TTM 27.59b / Enterprise Value 381.53b)
FCF Margin = 23.02% (FCF TTM 27.59b / Revenue TTM 119.86b)
Net Margin = 7.77% (Net Income TTM 9.31b / Revenue TTM 119.86b)
Gross Margin = 38.17% ((Revenue TTM 119.86b - Cost of Revenue TTM 74.11b) / Revenue TTM)
Gross Margin QoQ = none% (prev 22.77%)
Tobins Q-Ratio = 239.4 (set to none) (Enterprise Value 381.53b / Total Assets 1.59b)
Interest Expense / Debt = 18.99% (Interest Expense 25.71b / Debt 135.37b)
Taxrate = 30.10% (5.78b / 19.19b)
NOPAT = 7.49b (EBIT 10.72b * (1 - 30.10%))
Current Ratio = 3.11 (Total Current Assets 1.16b / Total Current Liabilities 371.0m)
Debt / Equity = 113.9 (Debt 135.37b / totalStockholderEquity, last quarter 1.19b)
Debt / EBITDA = -0.06 (Net Debt -844.0m / EBITDA 14.63b)
Debt / FCF = -0.03 (Net Debt -844.0m / FCF TTM 27.59b)
Total Stockholder Equity = 90.96b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.51% (Net Income 9.31b / Total Assets 1.59b)
RoE = 10.24% (Net Income TTM 9.31b / Total Stockholder Equity 90.96b)
RoCE = 9.40% (EBIT 10.72b / Capital Employed (Equity 90.96b + L.T.Debt 23.14b))
RoIC = 5.19% (NOPAT 7.49b / Invested Capital 144.52b)
WACC = 9.87% (E(247.00b)/V(382.37b) * Re(8.01%) + D(135.37b)/V(382.37b) * Rd(18.99%) * (1-Tc(0.30)))
Discount Rate = 8.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.18%
[DCF Debug] Terminal Value 70.88% ; FCFF base≈18.90b ; Y1≈18.23b ; Y5≈17.97b
Fair Price DCF = 31.38 (EV 233.58b - Net Debt -844.0m = Equity 234.42b / Shares 7.47b; r=9.87% [WACC]; 5y FCF grow -4.75% → 2.90% )
EPS Correlation: 46.80 | EPS CAGR: 1.17% | SUE: -1.75 | # QB: 0
Revenue Correlation: 7.37 | Revenue CAGR: -12.31% | SUE: -0.17 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.20 | Chg30d=-0.002 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=0.84 | Chg30d=+0.009 | Revisions Net=+1 | Growth EPS=+13.4% | Growth Revenue=+8.3%